After laying out a controversial model for the role of EBV in MS, Gavin Giovannoni went a step further...
CMSC 2023
Early indications from CMSC suggest we are on the verge of major new options for MS treatment. Two signaling...
Biomarkers seemed to be everywhere at CMSC. Presenters discussed the great need for clinical assays that can provide a...